Companies
Stevanato
EZ-fill® glass systems — Ready-to-use sterile vials.
- Country
- Italy
Coverage
| CN | EU | US | |
|---|---|---|---|
| therapeutics-platforms | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Revenue | €1.186 billion for fiscal year 2025 | ir.stevanatogroup.com · stevanatogroup.com |
| Headcount | 6,010 employees as of December 31, 2025 | stocknear.com · macrotrends.net · stevanatogroup.com |
| Production site | Piombino Dese (Italy), Latina (Italy), and Fishers (Indiana, U.S.) | ir.stevanatogroup.com · businesswire.com |
| Regulatory approval | EZ-fill® solutions are designed to meet GMP Annex 1 requirements, and VHP sterilization follows FDA guidance | stevanatogroup.com |
| Capacity | The group has been expanding production capacity for EZ-fill® products in Piombino Dese, Latina, and Fishers to meet demand medium confidence | ir.stevanatogroup.com · businesswire.com · stevanatogroup.com |
| Certification | Facilities operate with validated procedures in certified clean rooms medium confidence | dedecke-gmbh.de |
Independent sources: businesswire.com · dedecke-gmbh.de · macrotrends.net · stocknear.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Fill-finish & aseptic biomanufacturing | therapeutics-platforms | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.